Empatica Awarded New FDA Clearance for Cardiac Digital Biomarkers

Empatica receives US Food and Drug Administration (FDA) 510(k) clearance for two new digital biomarkers for its Empatica Health Monitoring Platform

What You Should Know:

– Empatica, a digital health and AI company, has obtained FDA 510(k) clearance for two new digital biomarkers, pulse rate, and respiratory rate, on its Empatica Health Monitoring Platform.

– This clearance expands the platform to include a total of six FDA-cleared digital biomarkers, out of the 128 digital measures supported, making it one of the most comprehensive solutions available for use in clinical trials.

– The Empatica Health Monitoring Platform comprises a complete remote health monitoring and data collection solution designed for research and healthcare professionals, utilizing data from the company’s medical-grade EmbracePlus wearable. In addition to the EmbracePlus wearable, the platform includes Empatica’s proprietary Care software suite, secure cloud infrastructure, and clinically validated digital biomarkers.

Researchers uncover role of the cerebellum in motor learning

Do you remember the name of your second-grade teacher or what you ate for lunch today? Those memories may be separated by decades, but both

October 15, 2024

HCA reports almost $1 billion more in charity care to Medicare than to its shareholders, drawing more taxpayer money

The country’s biggest hospital chain, HCA Healthcare, told the Centers for Medicare and Medicaid Services it doled out almost $1 billion more in financial assistance

April 8, 2024

Going green reduces COVID risk: Plant-based diets slash risk by up to 41%

Study finds plant-based diets reduce COVID-19 risk by 39-41% compared to meat-based diets, also associated with healthier BMI and lower obesity rates.

January 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.